UnitedHealth Group (NYSE: UNH) topped market expectations for earnings in the second quarter of 2019 while revenues matched forecasts. Shares rose by 1.6% in premarket hours on Thursday.
Total revenues grew 8% year-over-year to $60.6 billion, driven by double-digit percentage revenue growth at UnitedHealthcare Medicare & Retirement, OptumRx and OptumHealth.
Net earnings attributable to UnitedHealth Group common shareholders was $3.2 billion, or $3.42 per share, compared to $2.9 billion, or $2.98 per share, in the year-ago period. Adjusted EPS grew 15% year-over-year to $3.60.
During the quarter, operating cost ratio of 13.9% was up 110 basis points from the year-ago period, reflecting the deferral of the health insurance tax and continued effects of productivity advances and operating cost management disciplines. Consolidated medical care ratio increased 120 basis points year-over-year to 83.1%. Days claims payable was 49 days.
In the UnitedHealthcare segment, revenues grew 6% to $48.6 billion from the year-ago quarter, helped by revenue growth across most of its divisions. The business grew to serve 705,000 more people with medical benefits in the past year.
In the Optum segment, revenues grew 13.4% year-over-year to $28 billion, driven by revenue growth in all three units. OptumHealth served approx. 95 million people at quarter-end and the average revenue per consumer rose 17% year-over-year. OptumRx fulfilled 343 million adjusted scripts in the quarter, which was up 3.3% versus last year.
The company raised its outlook for fiscal year 2019 and now expects GAAP EPS of $13.95-14.15 and adjusted EPS of $14.70-14.90.
The business world is still struggling to come out of the virus-induced slowdown, but it seems almost every retail segment benefited from the pandemic at some point. The vaccination drive
General Mills (GIS): Three factors that are expected to help drive growth for the food company going forward
Shares of General Mills Inc. (NYSE: GIS) were up 3.2% on Wednesday after the company delivered better-than-expected results for the first quarter of 2022. Net sales rose 4% year-over-year to
It is estimated that the alternative investments industry has expanded at a compound annual rate of 10.2% over the past ten years and had $11 trillion in assets under management